Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Victor Manuel Diaz | M | 64 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 17 years |
| Wendy K. Dobson | M | 82 |
University of Toronto
| 31 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Renzi | M | 66 |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | - |
| Tammy Neske | F | 53 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | - |
| Joseph Cargnelli | M | 54 |
University of Toronto
| 6 years |
| Stefan Ioannou | M | - |
University of Toronto
| 10 years |
| Albert Cha | M | 51 |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | 9 years |
| Gary Ingenito | M | 68 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 3 years |
| David M. Clapper | M | 72 |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | 2 years |
| Edward Unkart | M | 74 |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | 2 years |
| Nawojka Marta Wachowiak | F | - |
University of Toronto
| 8 years |
| Shechar Dworski | M | - |
University of Toronto
| 6 years |
| John McKune | M | - |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | 2 years |
| Neil Seneviratne | M | - |
University of Toronto
| 4 years |
| Reza Zadno | M | 69 |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | 3 years |
| David Saul | M | - |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | - |
| Peter Lea | M | - |
University of Toronto
| 23 years |
| Dennis Logan | M | 57 |
University of Toronto
| 7 years |
| Stuart R. Nayman | M | - |
University of Toronto
| 3 years |
| Jae K. Kim | M | - |
University of Toronto
| 5 years |
| Jonathan Anschell | M | 56 |
University of Toronto
| 6 years |
| Arjun Kumar | M | - |
University of Toronto
| 8 years |
| Keith Katkin | M | 52 |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | 2 years |
| Mark Owens Thornton | M | 66 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 1 years |
| Steven Basta | M | 59 |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | 7 years |
| Eric Josipovic | M | - |
University of Toronto
| 6 years |
| Ka Yan Lau | M | 55 |
University of Toronto
| 6 years |
| Jeremy Rakusin | M | 55 |
University of Toronto
| 4 years |
| James Hughes | M | - |
University of Toronto
| 6 years |
| Kathleen Skerrett | F | - |
University of Toronto
| 7 years |
| Cheong Szeto | M | 54 |
University of Toronto
| 6 years |
| Tom Meyer | M | 56 |
University of Toronto
| 6 years |
| Andrzej Jankowski | M | - |
University of Toronto
| 9 years |
| Wai Yee Yiu | F | 56 |
University of Toronto
| 4 years |
| Dickson Cheng | M | 54 |
University of Toronto
| 4 years |
| Christopher Wei | M | 55 |
University of Toronto
| 4 years |
| Sebastian Jaimungal | M | - |
University of Toronto
| 4 years |
| Beata Antoszek | F | - |
University of Toronto
| 4 years |
| Brent Zanke | M | - |
University of Toronto
| 3 years |
| Yu Ting Freddy Goman Chong | M | 49 |
University of Toronto
| 4 years |
| Wai Hung Tam | M | 74 |
University of Toronto
| 2 years |
| Dorothy Dudek | F | - |
University of Toronto
| 4 years |
| Gregory P. Downey | M | - |
University of Toronto
| 4 years |
| Feisal Afzal | M | - |
University of Toronto
| 4 years |
| Monique Rabideau | F | - |
University of Toronto
| 3 years |
| Meredith Brill | F | 49 |
University of Toronto
| 4 years |
| Ji Xian Wang | M | 71 |
University of Toronto
| 3 years |
| Alison Wright | F | - |
University of Toronto
| 4 years |
| Asya Bradley | F | - |
University of Toronto
| 4 years |
| Lucy Chow | F | - |
University of Toronto
| 2 years |
| Ted Bader | M | - |
University of Toronto
| 4 years |
| Chi Chung Wong | M | 55 |
University of Toronto
| 4 years |
| Kelly Battle | F | - |
University of Toronto
| 4 years |
| Warren Louis Tang | M | 47 |
University of Toronto
| 4 years |
| Beata Caranci | F | - |
University of Toronto
| 4 years |
| Daniel Munro | M | - |
University of Toronto
| 5 years |
| Wai Leung Chan | M | 51 |
University of Toronto
| 4 years |
| Mark Kociancic | M | 54 |
University of Toronto
| 4 years |
| Navin Dyal | M | 48 |
University of Toronto
| 5 years |
| Heather Takahashi | F | - |
University of Toronto
| 3 years |
| Wai Kwan Li | M | 52 |
University of Toronto
| 4 years |
| Vishal Bhatia | M | - |
University of Toronto
| 4 years |
| Wing Tung Chow | M | 49 |
University of Toronto
| 4 years |
| Adam Schatzker | M | 52 |
University of Toronto
| 4 years |
| Pete Robic | M | - |
University of Toronto
| 4 years |
| Ben Jekic | M | - |
University of Toronto
| 4 years |
| John Charles Robert Aiken | M | - |
University of Toronto
| 2 years |
| Hiyam Jibry | M | - |
University of Toronto
| 4 years |
| Hoa Hong | F | - |
University of Toronto
| 4 years |
| Tom Nakamura | M | - |
University of Toronto
| 4 years |
| Joo-Hun Kim | M | - |
University of Toronto
| 4 years |
| Nessim Ramon Mansoor | M | - |
University of Toronto
| 4 years |
| Richard Gray | M | - |
University of Toronto
| 4 years |
| Paul Lechem | M | - |
University of Toronto
| 2 years |
| Ranyd Cass | M | - |
University of Toronto
| 3 years |
| Dino Bourdos | M | - |
University of Toronto
| 4 years |
| Heather E. L. Munroe-Blum | M | 73 |
University of Toronto
| 8 years |
| Noah Leslie Blackstein | M | - |
University of Toronto
| 4 years |
| Vincent Mifsud | M | - |
University of Toronto
| 4 years |
| Mark Steele | M | - |
University of Toronto
| 3 years |
| Kul Mani | M | - |
University of Toronto
| 4 years |
| Zhao Jie Li | M | 69 |
University of Toronto
| 3 years |
| Charles Walter Lannon | M | - |
University of Toronto
| 4 years |
| Edward Antecol | M | - |
University of Toronto
| 1 years |
| Kresimir Begic | M | - |
University of Toronto
| 4 years |
| Ewan Mason | M | - |
University of Toronto
| 2 years |
| Kam Wah Wong | M | 50 |
University of Toronto
| 4 years |
| Rabinder Grewal | F | - |
University of Toronto
| 4 years |
| Enrique Julian Joseph Bernard Lõpez de Mesa | M | 60 |
University of Toronto
| 2 years |
| Farhan Syed | M | - |
University of Toronto
| 4 years |
| Paul Lin | M | 61 |
University of Toronto
| 3 years |
| Sara Nicole Gottlieb | F | - |
University of Toronto
| 4 years |
| Gary Q. Lau | M | 51 |
University of Toronto
| 4 years |
| Simon Lockie | M | - |
University of Toronto
| 4 years |
| Andrew Morris | M | - |
University of Toronto
| 2 years |
| Craig Humphries | M | - |
University of Toronto
| 4 years |
| Trevor Haynes | M | 57 |
University of Toronto
| 4 years |
| Qin Lu | F | - |
University of Toronto
| 1 years |
| Anton B. Diener | M | - |
University of Toronto
| 4 years |
| Douglas Ching | M | - |
University of Toronto
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 91 | 91.00% |
| United States | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David M. Gravett
- Personal Network
